Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-635-6 | CAS number: 123-56-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Objective of study:
- absorption
- distribution
- other: elimination
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The absorption and elimination of succinimide have been investigated in healthy volunteers after the oral administration of a single dose of 10 g of succinimide per person. Succinimide was spectrophotometrically determined in serum by treating succinimide with hydroxylamine at pH 8.3 and measuring the absorbance of the resultant M-hydroxysuccinimide at 260 nm.
- GLP compliance:
- no
- Radiolabelling:
- no
- Species:
- human
- Strain:
- other: not applicable
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Three healthy volunteers. Age and weight: Nr.1: 35 years and 77 kg; Nr.2: 56 years and 95 kg; Nr.3:44 years and 65 kg.
- Route of administration:
- other: oral in solution (100 mL)
- Vehicle:
- not specified
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Three healthy volunteers were given 10 g of succinimide in solution (100 mL). Concentrations have been adjusted to a dose of 10g/75 kg i.e. 0.133 g/kg. The subjects had fasted overnight. - Duration and frequency of treatment / exposure:
- single administration
- Dose / conc.:
- 10 other: g in solution (100 mL)
- No. of animals per sex per dose / concentration:
- 3 healthy volunteers
- Control animals:
- no
- Positive control reference chemical:
- no
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY
- Tissues and body fluids sampled: serum
- Time and frequency of sampling: bebore administration, 0.5, 1, 2, 4, 6, 8 and 24 hours thereafter - Statistics:
- Elimination rate constants (kel) were calculated from the lines fitted, by the method of least squares , to the log blood concentration values versus time from 1 to 10 h, inclusive. The intercept gave the value of the apparent initial concentration (C0). Absorption rate constants (ka) were obtained by forcing a line through the residual concentration value at 0.5 h and the value of C0 at t=0. The maximum concentration (cmax) and the time to reach this maximum (tmax) were calculated from ka and kel as described; the fraction of the dose entering the body was assumed to be 1.
- Preliminary studies:
- no
- Type:
- absorption
- Results:
- Adsorption rate constant (ka) = 2.83 (1/h)
- Type:
- other: elimination serum
- Results:
- Elimination rate constants (kel) = 0.092 (1/h)
- Details on absorption:
- Adsorption rate constant (ka) = 2.83 (1/h)
- Details on distribution in tissues:
- no data
- Details on excretion:
- no data
- Toxicokinetic parameters:
- other: distribution coefficient: 0.63 ml/g
- Toxicokinetic parameters:
- C(time): 0h: 0.210 mg/ml
- Toxicokinetic parameters:
- Cmax: 0.187 mg/ml
- Toxicokinetic parameters:
- Tmax: 1.25 h
- Metabolites identified:
- not measured
- Details on metabolites:
- no data
- Conclusions:
- Comparison of the pharmacokinetic parameter values obtained for man and for rats after the oral administration of similar doses of succinimide shows that in man absorption is faster and elimination is slower. As a consequence, the maximum blood concentration occurs earlier and is higher. The distribution coefficient lies in the range which has been determined for other water soluble drugs. An accumulation of succinimide in organs or tissues is therefore unlikely.
- Executive summary:
The absorption and elimination of succinimide have been investigated in healthy volunteers after the oral administration of a single dose of 10 g succinimide per person. Succinimide was spectrophotometrically determined in serum by treating succinimide with hydroxylamine at pH 8.3 and masuring the absorbance of the resultant N-hydroxysuccinimide at 260 nm.
Comparison of the pharmacokinetic parameter values obtained for man and for rats after the oral administration of similar doses of succinimide shows that, in man absorption is faster and elimination is slower. As a consequence, the maximum blood concentration occurs earlier and is higher. The distribution coefficient lies in the range which has been determined for other water soluble drugs. An accumulation of succinimide in organs or tissues is therefore unlikely.
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Objective of study:
- absorption
- distribution
- excretion
- metabolism
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Only Abstract of publication is available, no information about guideline.- Principle of test: Pharmacokinetics and disposition of orally administered radiolabeled succinimide in the rat
- Short description of test conditions: The absorption, distribution, and elimination of radioactivity after the oral administration of 14C-Iabelled succinimide has been investigated at three dosage levels (0.09, 1.0 and 2.0 g/kg).
- Parameters analysed / observed: A comparison was made of the blood concentration of radioactivity after the intraperitoneal and oral administration of 0.5 g/kg of succinimide. The pharmacokinetics of orally administered succinimide have been fitted to a one-compartment open model - GLP compliance:
- no
- Specific details on test material used for the study:
- RADIOLABELLING INFORMATION (if applicable)
A mixture of [2,3-14C] succinic acid (5 mCi; 250 mg; radiochemical purity 97%. The Radiochemical Centre Ltd, Amersham), inactive succinic acid (40 g, 0.34 mole), and tertiary ammonium phosphate (0.4 g) in 25% aqueous ammonia solution (43.4 ml, 0.51 mole) was shaken for two hours at room temperature and then heated to 250 °C, with occasional shaking. This temperature was maintained until the water had evaporated. Succinimide was removed by sublimation (l24 °C, 5 mm Hg) and was recrystallized from acetone. Yield of succinimide: 22.5 g (68%), m.p. 123-124°C. Specific activity: 1.367 mCi/mmol. - Radiolabelling:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Tierzuchtanstalt Wilndrich, Altenberge
- Age at study initiation: no data
- Weight at study initiation: 150-220 g (not fasted; food was removed about 1 h before drug administration); 100-120 g (fasted rats; for the comparison of intraperitoneal and oral administration of succinimide; food was removed 16-18 h before drug administration
- Housing: The rats were placed into metabolism cages for the collection of urine and faeces, or of expired air
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data - Route of administration:
- oral: gavage
- Vehicle:
- other: aqueous solution
- Duration and frequency of treatment / exposure:
- single treatment
- Dose / conc.:
- 90 mg/kg bw/day
- Remarks:
- oral administration of 14C-labelled succinimide
- Dose / conc.:
- 500 mg/kg bw/day
- Remarks:
- for comparison of the bloss concentration of radioactivity after i.p. and oral administration
- Dose / conc.:
- 1 000 mg/kg bw/day
- Remarks:
- oral administration of 14C-labelled succinimide
- Dose / conc.:
- 2 000 mg/kg bw/day
- Remarks:
- oral administration of 14C-labelled succinimide
- No. of animals per sex per dose / concentration:
- no data
- Control animals:
- not specified
- Positive control reference chemical:
- not applicable
- Details on study design:
- no data
- Details on dosing and sampling:
- TOXICOKINETIC / PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled (delete / add / specify): urine, faeces, blood, plasma,
METABOLITE CHARACTERISATION STUDIES
Rats were killed 2, 4, 8 and 24 h after the oral administration of 14C-succinimide (1.0 g/kg), or 48 and 72 h after the oral administration of 2.0 g/kg. The plasma obtained after addition of HCI and centrifugation was lyophilized and then extracted with methanol. The methanol extract was concentrated and applied to TLC plates and developed in TLC solvent systems I and II.
The calculation of pharmacokinetic parameters followed the methods described by Wagner. Lines were fitted by the method of least squares.
Radioactivity measurements:
Radioactivity was determined with either a Nuclear Chicago Isocap/300 Model 6868 liquid scintillation spectrometer or a Berthold LB 2721 radiochromatogram scanner. Quench correction for liquid scintillation counting was made by internal standardization with 14C-toluene. Samples of blood or plasma, or rehydrated, homogenized organs or faeces, were digested in Soluene 350 (Packard), decolourized with H202/isopropanol and counted in Permablend III (Packard). Samples of the 2-phenylethylamine/methanol mixture used to trap CO2 in expired air or from the combustion of faeces, were counted in Permablend III. Samples of urine or methanol extracts were counted in the dioxane based scintillator, Diotol (Packard). The radioactivity on thin-layer and preparative chromatograms was detected with a radiochromatogram scanner. For quantitative measurement, zones of the thin-layer plates were scraped off and the radioactivity determined in a liquid scintillation mixture (Diotol or Instagel). - Statistics:
- The pharmacokinetics of orally administered succinimide have been fitted to a one-compartment open model.
- Type:
- absorption
- Results:
- see Table 1 in box "Any other information on results incl. tables".
- Type:
- distribution
- Results:
- see Table 1 in box "Any other information on results incl. tables".
- Type:
- excretion
- Results:
- see Table 1 in box "Any other information on results incl. tables".
- Type:
- metabolism
- Results:
- see Table 2 in box "Any other information on results incl. tables".
- Details on absorption:
- Maximum blood concentrations were seen after about 2 h.
Absorption and elimination were faster after dosage at 0.09 g/kg than after 1.0 and 2.0 g/kg.
Succinimide appeared to be well absorbed, and was evenly distributed throughout the body. - Details on distribution in tissues:
- Succinimide appeared to be well absorbed, and was evenly distributed throughout the body.
- Details on excretion:
- About 70 % of an administered dose of 1.0 g/kg was eliminated within 32 h: 50 % in urine, 4 % in the faeces, and 17 % as 14CO2 in the expired air.
- Metabolites identified:
- no
- Conclusions:
- Maximum blood concentrations were seen after 2 h. Succinimide was well absorbed and evenly distributed throughout the body.
About 70 % of an administered dose of 1.0 g/kg was eliminated within 32 h: 50 % in urine, 4 % in the faeces, and 17 % as 14CO2 in the expired air. - Executive summary:
The absorption, distribution, and elimination of radioactivity after the oral administration of 14C-labelled succinimide has been investigated at three dosage levels (0.09, 1.0, and 2.0 g/kg). A comparison was made of blood concentration of radioactivity after the intraperitoneal and oral administration of 0.5 g/kg of succinimide. The pharmacokinetics of orally administered succinimide have been fitted to a one-compartment open model.
Maximum blood concentrations were seen after 2 h. Succinimide was well absorbed and evenly distributed throughout the body.
About 70 % of an administered dose of 1.0 g/kg was eliminated within 32 h: 50 % in urine, 4 % in the faeces, and 17 % as 14CO2 in the expired air. Approximately 90 % of the radioactivity in the urine (0 -24 h) was succinimide.
Referenceopen allclose all
Table 1: Pharmacokinetic properties after oral administration of 14C-succinimide in rats
Dose (g/kg) | |||
0.09 | 1.0 | 2.0 | |
Absorption | |||
ka(1/h) | 1.5 | 0.90 | 1.11 |
t1/2a(h) | 0.46 | 0.77 | 0.63 |
Elimination | |||
kel(1/h) | 0.151 | 0.134 | 0.118 |
t1/2el(h) | 4.59 | 5.17 | 5.87 |
Apparent initial concentration | |||
C0(mg/mL) | 0.137 | 1.127 | 2.634 |
Apparent volume of distribution | |||
Vd(1/kg) | 0.66 | 0.89 | 0.76 |
Apparent total clearance | |||
Vdx kel(1/h) | 0.10 | 0.12 | 0.09 |
Maximum blood concentration | |||
cmax(mg/mL) | 0.106 | 0.807 | 2.017 |
Time to cmax | |||
tmax(h) | 1.7 | 2.49 | 2.26 |
Table 2: Relative amounts of succinimide and metabolites eliminated in urine up to 72 h after oral administration of 14C-succinimide
Radioactivity (% of total) | Relative amount of radioactivity in urine (0-24 h = 100) | ||
Time interval (h) | Succinimide | Metabolites | |
0-24 | 89 | 5 | 100 |
24-48 | 76 | 15 | 8 |
48-72 | 73 | 20 | 3 |
Description of key information
Rat
The absorption, distribution, and elimination of radioactivity after the oral administration of 14C-labelled succinimide has been investigated at three dosage levels (0.09, 1.0, and 2.0 g/kg). A comparison was made of blood concentration of radioactivity after the intraperitoneal and oral administration of 0.5 g/kg of succinimide. The pharmacokinetics of orally administered succinimide have been fitted to a one-compartment open model.
Maximum blood concentrations were seen after 2 h. Succinimide was well absorbed and evenly distributed throughout the body.
About 70 % of an administered dose of 1.0 g/kg was eliminated within 32 h: 50 % in urine, 4 % in the faeces, and 17 % as 14CO2 in the expired air. Approximately 90 % of the radioactivity in the urine (0 -24 h) was succinimide.
Human (males)
The absorption and elimination of succinimide have been investigated in healthy volunteers after the oral administration of a single dose of 10 g succinimide per person. Succinimide was spectrophotometrically determined in serum by treating succinimide with hydroxylamine at pH 8.3 and measuring the absorbance of the resultant N-hydroxysuccinimide at 260 nm.
Comparison of the pharmacokinetic parameter values obtained for man and for rats after the oral administration of similar doses of succinimide shows that in man absorption is faster and elimination is slower. As a consequence, the maximum blood concentration occurs earlier and is higher. The distribution coefficient lies in the range which has been determined for other water-soluble drugs. An accumulation of succinimide in organs or tissues is therefore unlikely.
Key value for chemical safety assessment
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.